Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reimann

Showing results (51-60 of 279) with videos related to

Pageof 28
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
IL-12/IL-18-dependent IFN-gamma release by murine dendritic cellsD Stober, R Schirmbeck, J Reimann
Leukemia & Lymphoma|May 16, 2000
Fibre content and cellularity of the bone marrow of the iliac crest, vertebral column and sternum in chronic myeloproliferative disordersA Kreft, J Reimann, H Choritz
European Journal of Immunology|June 8, 1999
Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expressionR Schirmbeck, O Gerstner, J Reimann
International Immunology|June 29, 1999
Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigenR Schirmbeck, K Melber, J Reimann
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumorsR Schirmbeck, W Böhm, J Reimann
European Journal of Immunology|August 1, 1997
Stress protein (hsp73)-mediated, TAP-independent processing of endogenous, truncated SV40 large T antigen for Db-restricted peptide presentationR Schirmbeck, W Böhm, J Reimann
Biological Chemistry Hoppe-Seyler|November 1, 1994
Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytesJ Reimann, W Böhm, R Schirmbeck
European Journal of Immunology|July 1, 1988
Development of autoreactive L3T4+ T cells from double-negative (L3T4-/Ly-2-) Thy-1+ spleen cells of normal miceJ Reimann, A Bellan, P Conradt
Fortschritte Der Medizin|April 10, 1997
[Hypertension and gastrointestinal diseases]M C Müller, H J Reimann
Cancer Immunology, Immunotherapy : CII|June 1, 1997
Targeting an anti-viral CD8+ T cell response to a growing tumor facilitates its rejectionW Böhm, R Schirmbeck, J Reimann
Pageof 28

Showing results (51-60 of 279) with videos related to

Sort By:
Pageof 28
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
IL-12/IL-18-dependent IFN-gamma release by murine dendritic cellsD Stober, R Schirmbeck, J Reimann
Leukemia & Lymphoma|May 16, 2000
Fibre content and cellularity of the bone marrow of the iliac crest, vertebral column and sternum in chronic myeloproliferative disordersA Kreft, J Reimann, H Choritz
European Journal of Immunology|June 8, 1999
Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expressionR Schirmbeck, O Gerstner, J Reimann
International Immunology|June 29, 1999
Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigenR Schirmbeck, K Melber, J Reimann
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumorsR Schirmbeck, W Böhm, J Reimann
European Journal of Immunology|August 1, 1997
Stress protein (hsp73)-mediated, TAP-independent processing of endogenous, truncated SV40 large T antigen for Db-restricted peptide presentationR Schirmbeck, W Böhm, J Reimann
Biological Chemistry Hoppe-Seyler|November 1, 1994
Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytesJ Reimann, W Böhm, R Schirmbeck
European Journal of Immunology|July 1, 1988
Development of autoreactive L3T4+ T cells from double-negative (L3T4-/Ly-2-) Thy-1+ spleen cells of normal miceJ Reimann, A Bellan, P Conradt
Fortschritte Der Medizin|April 10, 1997
[Hypertension and gastrointestinal diseases]M C Müller, H J Reimann
Cancer Immunology, Immunotherapy : CII|June 1, 1997
Targeting an anti-viral CD8+ T cell response to a growing tumor facilitates its rejectionW Böhm, R Schirmbeck, J Reimann
Pageof 28